Dependence receptors: New weapon to inhibit tumors?

Tuesday, March 9, 2010 - 12:35 in Health & Medicine

The interaction of a ligand (Neurotrophine-3) and its dependence receptor (TrkC) constitutes a novel mechanism for tumor control in pediatric cancers such as neuroblastoma, and may also be important to the inhibition of other cancers such as breast cancer. These findings support the concept concerning the design of anti-tumor therapeutic strategies targeting a new type of receptor, the dependence receptor. These receptors are indeed able to induce cell death when they are deprived of their ligand.

Read the whole article on Science Daily

More from Science Daily

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net